AN2 Therapeutics Inc (ANTX)

1.99 -0.05 (-2.45%) USD  |  NASDAQ  |  May 31, 16:00
2.02 +0.03 (+1.51%) After-Hours: 20:00
More

AN2 Therapeutics Preferred Securities out of Shareholders Equity (Quarterly)

Preferred Securities out of Shareholders Equity (Quarterly) Chart

View Preferred Securities out of Shareholders Equity (Quarterly) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Preferred Securities out of Shareholders Equity (Quarterly) Data

View and export this data back to 2022. Upgrade now.
Date Value
March 31, 2022 --

Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

--
Minimum
Mar 2022
--
Maximum
Mar 2022
--
Average
--
Median
Mar 2022

Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Revance Therapeutics Inc --
Viking Therapeutics Inc --
VYNE Therapeutics Inc --
Aquestive Therapeutics Inc --
Humacyte Inc --